BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ivantis, Inc. Enrolls First Patient for U.S. Clinical Study on Glaucoma


3/6/2012 10:57:07 AM

IRVINE, Calif.--(BUSINESS WIRE)--Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The HydrusTM Microstent is the world’s first intracanalicular (“in the canal”) scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States. The HYDRUS IV Study will include patients with glaucoma who are undergoing cataract surgery and also taking eye drop medication for their glaucoma. Per the study design, patients will either receive cataract surgery alone or cataract surgery plus the Hydrus Microstent. While the first phase of the study is intended to initially analyze results from a smaller number of patients, it is anticipated that more than 500 patients in over 25 centers globally will ultimately be included.

Read at BioSpace.com

   
Glaucoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES